Patents by Inventor David P. MEININGER

David P. MEININGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BTLA-BINDING ANTIBODIES FOR MODULATING IMMUNE RESPONSE AND TREATING DISEASE
    Publication number: 20230340123
    Abstract: The invention provides novel anti-BTLA antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
    Type: Application
    Filed: July 10, 2022
    Publication date: October 26, 2023
    Inventors: Brian A. ZABEL, John A. LIPPINCOTT, Yayue ZHENG, Megha Vaman RAO, Miao TAN, David P. MEININGER
  • BTLA-binding antibodies for modulating immune response and treating disease
    Patent number: 11384146
    Abstract: The invention provides novel anti-BTLA antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: July 12, 2022
    Assignees: Curia IP Holdings, LLC, TRIANNI, Inc.
    Inventors: Brian A. Zabel, John A. Lippincott, Yayue Zheng, Megha Vaman Rao, Miao Tan, David P. Meininger
  • BTLA-BINDING ANTIBODIES FOR MODULATING IMMUNE RESPONSE AND TREATING DISEASE
    Publication number: 20200325230
    Abstract: The invention provides novel anti-BTLA antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.
    Type: Application
    Filed: March 31, 2020
    Publication date: October 15, 2020
    Inventors: Brian A. Zabel, John A. Lippincott, Yayue Zheng, Megha Vaman Rao, Miao Tan, David P. Meininger
  • Modified Lecithin-Cholesterol Acyltransferase Enzymes
    Publication number: 20090081182
    Abstract: The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
    Type: Application
    Filed: July 25, 2008
    Publication date: March 26, 2009
    Applicant: AMGEN INC.
    Inventors: Tom BOONE, David P. MEININGER, Margrit SCHWARZ, Bei SHAN, Wenyan SHEN, Mingyue ZHOU